These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 225023)

  • 1. Antitumor activity and lymphoreticular stimulation properties of fractions isolated from Corynebacterium parvum.
    Cantrell JL; Wheat RW
    Cancer Res; 1979 Sep; 39(9):3554-63. PubMed ID: 225023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of the antitumor immunity potentiated by anaerobic Corynebacterium parvum].
    Miyata H
    Fukuoka Igaku Zasshi; 1983 Jul; 74(7):451-69. PubMed ID: 6662469
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
    Hanna N
    Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of Corynebacterium parvum.
    Milas L; Scott MT
    Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in mice.
    Lichtenstein A; Tuttle R; Cantrell J; Zighelboim J
    J Natl Cancer Inst; 1982 Aug; 69(2):495-501. PubMed ID: 6213807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and biological properties of a purified lymphoreticular-stimulating fraction of Corynebacterium parvum (Propionibacterium acnes type I).
    Adlam C; Reid DE; Marshall AJ; Torkington P
    J Med Microbiol; 1979 Nov; 12(4):429-40. PubMed ID: 513108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
    Conley FK; Remington JS
    J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions.
    Millman I; Scott AW; Halbherr T
    Cancer Res; 1977 Nov; 37(11):4150-5. PubMed ID: 409491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical properties of the principle in C. parvum that produces splenomegaly in mice.
    Riveros-Moreno V; Niblock A
    Immunology; 1979 Mar; 36(3):495-9. PubMed ID: 220183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible mechanisms underlying the induction of cytotoxic macrophages by Corynebacterium parvum: in vitro induction of cytotoxicity in normal macrophages by immune lymphocytes.
    Cullen RT; Ghaffar A
    J Reticuloendothel Soc; 1978 Oct; 24(4):339-49. PubMed ID: 81874
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitogenicity of Corynebacterium parvum for mouse lymphocytes.
    Zola H
    Clin Exp Immunol; 1975 Dec; 22(3):514-21. PubMed ID: 817854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system.
    McBride WH; Dawes J; Dunbar N; Ghaffar A; Woodruff MF
    Immunology; 1975 Jan; 28(1):49-58. PubMed ID: 1116870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation of macrophages by Corynebacterium parvum: effect of anti-complementary agents cobra venom factor and sodium cyanate.
    Ghaffar A
    J Reticuloendothel Soc; 1980 Mar; 27(3):327-35. PubMed ID: 7365736
    [No Abstract]   [Full Text] [Related]  

  • 18. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
    Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
    J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ distribution of technetium-99m-labeled corynebacterium parvum in normal and tumor-bearing mice.
    Barth RF; Singla O
    Cancer Res; 1978 Jan; 38(1):32-4. PubMed ID: 618580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.